HIV Citation List: May 22 - June 4, 2015
PubMed Citations
1. Subtype-specific Analysis of the K65r Substitution in HIV-1 That Confers Hypersusceptibility to a Novel Nucleotide-competing Reverse Transcriptase Inhibitor. Xu, H.T., S.P. Colby-Germinario, P.K. Quashie, R. Bethell, and M.A. Wainberg. Antimicrobial Agents and Chemotherapy, 2015. 59(6): p. 3189-3196. PMID[25779585].
[PubMed]. HIV_0522-060415.
2. MicroRNA-155 Reinforces HIV Latency. Ruelas, D.S., J.K. Chan, E. Oh, A.J. Heidersbach, A.M. Hebbeler, L. Chavez, E. Verdin, M. Rape, and W.C. Greene. Journal of Biological Chemistry, 2015. 290(22): p. 13736-13748. PMID[25873391].
[PubMed]. HIV_0522-060415.
3. Identification of anti-HIV Active Dicaffeoylquinic- and Tricaffeoylquinic acids in Helichrysum populifolium by NMR-based Metabolomic Guided Fractionation. Heyman, H.M., F. Senejoux, I. Seibert, T. Klimkait, V.J. Maharaj, and J.J. Meyer. Fitoterapia, 2015. 103: p. 155-164. PMID[25841639].
[PubMed]. HIV_0522-060415.
4. Design, Synthesis, and Biological Evaluation of 1-(Thiophen-2-yl)-9H-pyrido[3,4-b]Indole Derivatives as anti-HIV-1 Agents. Ashok, P., C.L. Lu, S. Chander, Y.T. Zheng, and S. Murugesan. Chemical Biology & Drug Design, 2015. 85(6): p. 722-728. PMID[25328020].
[PubMed]. HIV_0522-060415.
ISI Web of Knowledge Citations
5. Antiviral Activity of a Zymolytic Grain Based Extract on Human Immunodeficiency Virus Type 1 in Vitro. Wang, C., D. Liu, X.H. Guo, B. Yu, H. Wu, H.H. Zhang, J.X. Wu, C.L. Jiang, W. Kong, and X.H. Yu. Evidence-Based Complementary and Alternative Medicine, 2015. 642327: 9pp . ISI[000354316800001].
[WOS]. HIV_0522-060415.
6. Novel 3'-Processing Integrase Activity Assay by Real-time PCR for Screening and Identification of HIV-1 Integrase Inhibitors. Sakkhachornphop, S., W. Thongkum, and C. Tayapiwatana. Biomed Research International, 2015. 853891: 7pp. ISI[000354698100001].
[WOS]. HIV_0522-060415.
7. Griffithsin Tandemers: Flexible and Potent Lectin Inhibitors of the Human Immunodeficiency Virus. Moulaei, T., K.B. Alexandre, S.R. Shenoy, J.R. Meyerson, L.R.H. Krumpe, B. Constantine, J. Wilson, R.W. Buckheit, J.B. McMahon, S. Subramaniam, A. Wlodawer, and B.R. O'Keefe. Retrovirology, 2015. 12(6): 14pp. ISI[000354247900001].
[WOS]. HIV_0522-060415.
8. Inhibition of Drug-resistant HIV by Targeting Cellular CDK9 in Humanized Mice. Heredia, A., N. Le, S. Medina-Moreno, J. Zapata, M. Reitz, J. Bryant, and R. Redfield. JAIDS-Journal of Acquired Immune Deficiency Syndromes, 2014. 67: p. 77-77. ISI[000354119800077].
[WOS]. HIV_0522-060415.
9. New Hybrids between Triterpenoid acids and Nucleoside HIV-RT Inhibitors. Dang, A.T.T., C.T. Pham, T.A. Le, H.H. Truong, H.T.T. Vu, A.T. Soldatenkov, and T.V. Nguyen. Mendeleev Communications, 2015. 25(2): p. 96-98. ISI[000353610200004].
[WOS]. HIV_0522-060415.
10. Armochaetoglobins K-R, anti-HIV Pyrrole-based Cytochalasans from Chaetomium globosum TWL-1. Chen, C.M., H.C. Zhu, J.P. Wang, J. Yang, X.N. Li, J. Wang, K.L. Chen, Y.Y. Wang, Z.W. Luo, G.M. Yao, Y.B. Xue, and Y.H. Zhang. European Journal of Organic Chemistry, 2015(14): p. 3086-3094. ISI[000354212000015].
[WOS]. HIV_0522-060415.
11. Potent anti-HIV Chemokine Analogs Direct Post-endocytic Sorting of CCR5. Bonsch, C., M. Munteanu, I. Rossitto-Borlat, A. Furstenberg, and O. Hartley. PloS One, 2015. 10(4). ISI[000353711600148].
[WOS]. HIV_0522-060415.
Patent Citations
12. Preparation of Heterocyclyloxyphenoxyethyl Substituted Pyrimidine-2,4(1H,3H)-diones for Treating HIV Infections. Jorgensen, W.L. and K.S. Anderson. Patent. 2015. 2014-14509301 20150105351: 66pp.
[Patent]. HIV_0522-060415.
13. Preparation of Sulfonylaminocarbonyl amino acid amides as Inhibitors of Human Immunodeficiency Virus Replication and Use for the Treatment of HIV Infection. Pendri, A., G. Li, J.A. Bender, Z. Yang, A.X. Wang, B.R. Beno, R.A. Fridell, M. Belema, N.A. Meanwell, and R.G. Gentles. Patent. 2015. 2014-US61870 2015061518: 378pp.
[Patent]. HIV_0522-060415.